EQT, Genie Energy And Other Big Stocks Moving Lower On Monday

U.S. stocks were lower, with the Dow Jones index falling more than 150 points on Monday.

Shares of EQT Corporation (NYSE:EQT) fell sharply during Monday’s session after the company announced that it entered into a definitive merger agreement to acquire Equitrans Midstream.

EQT shares fell 8.4% to $34.37 on Monday.

Here are some other big stocks recording gains in today’s session.

• Ventyx Biosciences, Inc. (NASDAQ:VTYX) shares tumbled 18.5% to $8.09. Ventyx Biosciences reported clinical data for its NLRP3 inhibitor portfolio and issued pipeline updates at Virtual Investor Event.
• MoneyLion Inc. (NYSE:ML) dipped 15% to $63.36.
• Genie Energy Ltd. (NYSE:GNE) declined 12% to $16.67 following fourth-quarter results.
• Nanobiotix S.A. (NASDAQ:NBTX) dipped 9.8% to $6.35.
• Pagaya Technologies Ltd. (NASDAQ:PGY) fell 9.6% to $16.54.
• Bitfarms Ltd. (NASDAQ:BITF) fell 9% to $2.4290. Bitfarms purchased additional miners to reach 21 EH/s in 2024.
• Quantum-Si incorporated (NASDAQ:QSI) declined 9% to $2.03.
• Super Micro Computer, Inc. (NASDAQ:SMCI) dipped 8.8% to $1,039.60.
• MannKind Corporation (NASDAQ:MNKD) dipped 8.7% to $4.81. MannKind announced initial meal challenge data from INHALE-3 Phase 4 U.S. trial comparing afrezza head-to-head with multiple daily injections and insulin pumps.
• Applied Therapeutics, Inc. (NASDAQ:APLT) fell 8.4% to $6.35.
• Poseida Therapeutics, Inc. (NASDAQ:PSTX) declined 8.1% to $3.74.
• Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) fell 7.6% to $30.90. Arrowhead Pharmaceuticals recently announced that it initiated its Phase 1/2a study of ARO-DM1 for the treatment of type 1 myotonic dystrophy.
• Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT) dipped 7.6% to $10.31. Arcutis promoted Todd Tucker to Chief Human Resources Officer.
• Carvana Co. (NYSE:CVNA) fell 6.3% to $79.96.
• Celestica Inc. (NYSE:CLS) fell 5.7% to $43.45. Cormark Securities analyst Jesse Pytlak initiated coverage on Celestica with a Buy rating and announced a price target of $56.
• NOVONIX Limited (NYSE:NVX) fell 5.2% to $2.37.

Now Read This: Top 5 Risk Off Stocks That May Plunge This Quarter